Literature DB >> 3977194

Erythromelalgia caused by platelet-mediated arteriolar inflammation and thrombosis in thrombocythemia.

J J Michiels, J Abels, J Steketee, H H van Vliet, V D Vuzevski.   

Abstract

Erythromelalgia was the presenting symptom in 26 of 40 patients with thrombocythemia in its primary form or when associated with polycythemia vera. The localized painful burning, redness, and warm congestion in the extremities could be accurately documented with thermography. Skin punch biopsy samples taken from the affected areas showed typical arteriolar inflammation, fibromuscular intima proliferation, and thrombotic occlusions. Erythromelalgia often progressed to ischemic acrocyanosis or necrosis in toes or fingers. Complete relief of pain and restoration of microvascular circulation disturbances was obtained with the cyclo-oxygenase inhibitors aspirin and indomethacin, but not with sodium-salicylate or the platelet inhibitors dipyridamole, sulfinpyrazone, ticlopidine, and dazoxiben. The erythromelalgia was alleviated during busulfan-induced remissions of thrombocythemia and its recurrence coincided with relapsing thrombocythemia. These observations suggest a causal relationship between erythromelalgia and thrombocythemia, in which platelet-mediated inflammatory and occlusive arteriolar changes play a part in the etiology of erythromelalgia.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3977194     DOI: 10.7326/0003-4819-102-4-466

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  26 in total

1.  Three types of erythromelalgia.

Authors:  J P Drenth; J J Michiels
Journal:  BMJ       Date:  1990-09-08

2.  A Study of Haemostatic Parameters in Patients of Chronic Myeloid Leukaemia.

Authors:  Ankur Jain; Naresh Gupta; Tejinder Singh; Sunita Agarwal
Journal:  J Clin Diagn Res       Date:  2016-07-01

3.  Coronary vasculopathy in polycythemia vera.

Authors:  B Hermanns; S Handt; J Kindler; L Füzesi
Journal:  Pathol Oncol Res       Date:  1998       Impact factor: 3.201

4.  2016 WHO Clinical Molecular and Pathological Criteria for Classification and Staging of Myeloproliferative Neoplasms (MPN) Caused by MPN Driver Mutations in the JAK2, MPL and CALR Genes in the Context of New 2016 WHO Classification: Prognostic and Therapeutic Implications.

Authors:  Jan Jacques Michiels; Mihaela Tevet; Adrian Trifa; Emilia Niculescu-Mizil; Anca Lupu; Ana Maria Vladareanu; Horia Bumbea; Anca Ilea; Camelia Dobrea; Daniela Georgescu; Oana Patrinoiu; Mihaela Popescu; Meilin Murat; Cornel Dragan; Felicia Mihai; Sabina Zurac; Silvana Angelescu; Anamaria Iova; Alina Popa; Rodica Gogulescu; Violeta Popov
Journal:  Maedica (Bucur)       Date:  2016-03

5.  Erythromelalgia induced by nicardipine.

Authors:  J P Drenth
Journal:  BMJ       Date:  1989-06-10

6.  Erythromelalgia induced by nicardipine.

Authors:  H Levesque; N Moore
Journal:  BMJ       Date:  1989-07-29

7.  Erythromelalgia.

Authors:  Mark D. P. Davis; Thom Rooke
Journal:  Curr Treat Options Cardiovasc Med       Date:  2002-06

8.  Familial essential thrombocythemia: clinical characteristics of 11 cases in one family.

Authors:  R J Schlemper; A P van der Maas; J C Eikenboom
Journal:  Ann Hematol       Date:  1994-03       Impact factor: 3.673

9.  Erythromelalgia as a presenting manifestation in a patient with essential thrombocythemia complicating renovascular hypertension due to unilateral renal artery stenosis.

Authors:  Jin-Wuk Hur; Young-Yiul Lee; Woong-Soo Lee; Jae-Bum Jun
Journal:  Rheumatol Int       Date:  2005-03-05       Impact factor: 2.631

10.  Erythromelalgia.

Authors:  Mark D P Davis; Thom Rooke
Journal:  Curr Treat Options Cardiovasc Med       Date:  2006-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.